10x Genomics (MEX:TXG) Total Assets : MXN18,482 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is 10x Genomics Total Assets?

10x Genomics's Total Assets for the quarter that ended in Mar. 2025 was MXN18,482 Mil.

During the past 12 months, 10x Genomics's average Total Assets Growth Rate was -13.50% per year. During the past 3 years, the average Total Assets Growth Rate was 6.80% per year. During the past 5 years, the average Total Assets Growth Rate was 25.50% per year.

During the past 8 years, 10x Genomics's highest 3-Year average Total Assets Growth Rate was 112.40%. The lowest was 6.80%. And the median was 48.80%.

Total Assets is connected with ROA %. 10x Genomics's annualized ROA % for the quarter that ended in Mar. 2025 was -14.94%. Total Assets is also linked to Revenue through Asset Turnover. 10x Genomics's Asset Turnover for the quarter that ended in Mar. 2025 was 0.17.

10x Genomics Total Assets Historical Data

The historical data trend for 10x Genomics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Total Assets Chart

10x Genomics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

18,486.45

20,900.20

20,060.99

16,382.58

19,158.80

10x Genomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Assets	Get a 7-Day Free Trial															15,316.90	17,031.61	18,465.45	19,158.80	18,481.80

10x Genomics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

10x Genomics's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	14810.342	+	4348.455
	=	19,159

10x Genomics's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2025 )	+	Total Liabilities (Q: Mar. 2025 )
	=	14461.799	+	4019.995
	=	18,482

10x Genomics (MEX:TXG) Total Assets Explanation

Total Assets is connected with ROA %.

10x Genomics's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %	=	Net Income (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	-2811.612	/	( (19158.797	+	18481.795)	/ 2 )
	=	-2811.612	/	18820.296
	=	-14.94 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

10x Genomics's Asset Turnover for the quarter that ended in Mar. 2025 is

	Asset Turnover
=	Revenue (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
=	3168.627	/	( (19158.797	+	18481.795)	/ 2 )
=	3168.627	/	18820.296
=	0.17

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

10x Genomics Total Assets Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

10x Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (MEX:TXG) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

TXG:USA 0A88:UK 1KJ:Germany

Address

6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588

Website

https://www.10xgenomics.com

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).